Skip to content

South Korea becoming a pharma manufacturing hub, according to CPhI Korea

The fourth CPhI Korea is set to take place in August in Seoul, where the event organisers have revealed that there will be a 13% rise in the number of exhibitors and double the amount of overseas buyers since 2015.

South Korea becoming a pharma manufacturing hub, according to CPhI Korea
Published: | 1 min read

The fourth CPhI Korea is set to take place in August in Seoul, where the event organisers have revealed that there will be a 13% rise in the number of exhibitors and double the amount of overseas buyers since 2015.

South Korea flag

This surge in numbers reflects the growing interest in the South Korean pharma economy, according to UBM — organisers of the event — in a recent press release. South Korea has become the third largest pharma region in Asia, with forecasted growth from $18.6 billion last year to $20.4 billion on 2020.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information